Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Author:
Funder
Deutsche Forschungsgemeinschaft
Else Kröner-Fresenius-Stiftung
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Genetics,Immunology
Link
https://www.nature.com/articles/s41435-020-00109-1.pdf
Reference121 articles.
1. Huber EM, Basler M, Schwab R, Heinemeyer W, Kirk CJ, Groettrup M, et al. Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell. 2012;148:727–38.
2. Schmidt C, Berger T, Groettrup M, Basler M. Immunoproteasome inhibition impairs T and B cell activation by restraining ERK signaling and proteostasis. Front Immunol. 2018;9:2386.
3. Basler M, Claus M, Klawitter M, Goebel H, Groettrup M. Immunoproteasome inhibition selectively kills human CD14(+) monocytes and as a result dampens IL-23 secretion. J Immunol. 2019;203:1776–85.
4. Vigneron N, Abi Habib J, Van den Eynde BJ. Learning from the proteasome how to fine-tune cancer immunotherapy. Trends Cancer. 2017;3:726–41.
5. Kisselev AF, van der Linden WA, Overkleeft HS. Proteasome inhibitors: an expanding army attacking a unique target. Chem Biol. 2012;19:99–115.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioengineering of syrbactin megasynthetases for immunoproteasome inhibitor production;Chem;2024-08
2. Optimization of α-amido boronic acids via cryo-electron microscopy analysis: Discovery of a novel highly selective immunoproteasome subunit LMP7 (β5i)/LMP2 (β1i) dual inhibitor;Bioorganic & Medicinal Chemistry;2024-07
3. Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance;European Journal of Medicinal Chemistry;2024-05
4. Proteasome composition in immune cells implies special immune‐cell‐specific immunoproteasome function;European Journal of Immunology;2024-03-08
5. Non-peptidic immunoproteasome β5i-selective inhibitor as potential treatment for idiopathic pulmonary fibrosis: Virtual screening, hit evolution and lead identification;European Journal of Medicinal Chemistry;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3